As of Wednesday, April 29, Senseonics Holdings, Inc.’s SENS share price has dipped by 5.98%, which has investors questioning ...
Senseonics Holdings (AMEX:SENS) is preparing to release its quarterly earnings on Monday, 2026-03-02. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...
Hosted on MSN
Wall Street analysts predict a 124.49% upside in Senseonics (SENS): Here's what you should know
Senseonics Holdings (SENS) closed the last trading session at $8.33, gaining 14.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...
The Middle East and Africa Continuous Glucose Monitoring (CGM) market is set for growth, driven by increasing diabetes rates, technological advancements, and healthcare awareness. Projected to rise ...
Senseonics Holdings ( (SENS)) just unveiled an update. Senseonics Holdings, Inc. has updated its equity distribution agreement with Goldman Sachs to allow the sale of up to $55 million in common stock ...
GERMANTOWN, Md., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable ...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...
Implantable CGM company Senseonics has received approval from the FDA for the non-adjunctive indication for its Eversense device. Senseonics is only the third company to secure this indication, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results